Company

Protagonist Therapeutics

Protagonist Therapeutics is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.

Latest on Protagonist Therapeutics

  • [via Johnson & Johnson]
  • 13F: Moody Aldrich Partners Llc holds Protagonist Therapeutics ($6M)
  • 13F: Johnson & Johnson holds Protagonist Therapeutics ($345M)

Connections

5 entities linked to Protagonist Therapeutics across the news graph.